Table 1 Inclusion/exclusion criteria

Population

Humans

Animals

All ages

Plants

All sexes

Infection with antimicrobial resistant organism

Intervention

Not applicable

Not applicable

Comparator

Not applicable

Not applicable

Outcomes

Associated health burden, to include but not restricted to:

Morbidity; for example excess length of stay in hospital

Mortality

Health-related quality of life only

Associated Healthcare cost burden, to include but not restricted to:

Resource use

Opportunity cost

Molecular biology only

Economic burden, to include but not restricted to:

Costs associated with loss of productivity and reduced labour force

Work-loss hours per/case episode

Epidemiology only

Secondary burden from not being able to use antibiotics in ways previously or currently used in healthcare, to include but not restricted to:

Reduced surgery Reduced use in chemotherapy and similar therapies

Outcomes associated with the evaluation of an intervention such as clinical cure rate only

Study design

Case–control studies

Editorials

Cohort studies

Letters

Cross–sectional studies

Case series report

Longitudinal studies

Conference abstracts/reports

Randomised controlled trials

Evaluations of treatments/interventions

Modelling studies

Reviews

Economic evaluations

Other

English language